Early innate immune signatures correlate with Ad26.COV2.S vaccine durability and protective efficacy
This study demonstrates that early innate immune activation signatures, observed as early as day 1 post-vaccination in both rhesus macaques and humans, positively correlate with the Ad26.COV2.S vaccine's immunogenicity and protective efficacy against SARS-CoV-2.